• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Up and Coming

Up and Coming

April 13, 2020

This feature highlights changes in clinical trial organizations’ personnel.

AlloVir

Late-clinical stage T-cell immunotherapy company AlloVir appointed Ugo Perlingieri to the position of general manager of Europe and Middle East operations. Perlingieri comes to AlloVir from Alexion Pharma Italy, where he served as vice president and general manager.

Calliditas Therapeutics

Calliditas Therapeutics announced Richard Philipson will become the company’s chief medical officer. Philipson was most recently chief medical officer of UK biotech company Trizell.

e-therapeutics

Laura Roca-Alonso, Gyroscope Therapeutics’ previous director of business development, has joined AI drug discovery biotech e-therapeutics as its chief business officer.

Flagship Biosciences

Geoff Metcalf has been named vice president of clinical diagnostics of Flagship Biosciences. Previously, Metcalf was head of strategic planning at Siemens Diagnostics.

Gadeta

Marco Londei will now serve as CEO of Gadeta. Before joining Gadeta, Londei was chief development officer and chief medical officer of AnaptysBio.

GlycoMimetics

Myra Rosario Herrle, the most recent senior director of AbbVie’s oncology global regulatory strategy, has been appointed vice president of regulatory affairs at GlycoMimetics.

Immunomedics

Harout Semerjian has been named president and CEO of Immunomedics. Semerjian most recently held the position of executive vice president and chief commercial officer at Ipsen.

ImmunoPrecise

ImmunoPrecise appointed Yasmina Abdiche to the role of chief scientific officer. Prior to this position, Abdiche was chief scientific officer at Carterra.

Kyowa Kirin

Gary Zieziula has been named president of Kyowa Kirin’s North America division. Zieziula’s most recent position was president and managing director of EMD Serono’s North America division.

Locana

Locana appointed Micah Mackison to the role of chief business officer. Mackison joins the company from Assembly Biosciences, where he served as senior vice president of corporate development and strategy.

Lumos Pharma

John McKew, chief scientific officer of Lumos Pharma, has been promoted by the company to also serve as chief operating officer.

Owlstone Medical

Neil Tween will now serve as chief financial officer of Owlstone Medical. Tween leaves his previous position as vice president and group financial controller of GW Pharmaceuticals to join Owlstone.

Polyneuron

Debra Barker has been appointed by Polyneuron to the role of chief medical officer. Previously, Barker was chief medical and development officer of Polyphor.

Precision NanoSystems

Precision NanoSystems announced the hiring of Andrew Geall, who will take on the role of chief scientific officer. Geall was most recently the RNA vaccine platform leader at Novartis Vaccines.

Seres Therapeutics

Lisa von Moltke has been named chief medical officer of Seres Therapeutics. Prior to taking this role, von Moltke served as head of clinical development at Alkermes.

Vor Biopharma

Oncology company Vor Biopharma named Robert Pietrusko the company’s new chief regulatory and quality officer. Pietrusko was most recently vice president of global regulatory affairs and quality and executive officer at ViroPharma.

Yuyu Pharma

Robert Yu has been appointed president and CEO of Korea-based Yuyu Pharma. Most recently, Yu was Yuyu’s chief operating officer.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing